1[1]Fanslow WC, Clifford KN, Seaman M, et al. Recombinant CD40 ligand exerts potent biologic effects on T cells.J Immunol, 1994,152:4262-4267
2[2]Grewal IS, Flavell RA. CD40 and CD154 in cell mediated immunity. Annu Rev Immunol, 1998,16:111-135
3[3]Cella M,Scheidegger D,Palmer-Lehmannk,et al. Ligation of CD40 on dendritic cells trigger production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med,1996,184: 747-752
4[4]Callard RE, Armitage R J, Fanslow W, et al. CD40 ligand and its role in Xlinked hyper-IgM syndrome. Immunol Today, 1993,14: 559-564
5[5]Planken EV, Dijkstra NH, Willemze R, et al. Proliferation of B cell malignancies in all stages of differentiation up on stimulation in the CD40 system. Leukemia, 1996,10:488
6[6]Marilyn R. CD40-mediated signaling in B cells balancing cell survival, growth and death. J Immunol, 1996,156: 2345-2348
7[7]Lenschow DJ,Walunas TL,Bluestone JA,et al. CD2s/B7 system of T cell costimutation. Annu Rev Immunol, 1996,14: 233-247
8[8]Andreas H, Anna M, Dittrich, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature, 1999,397:263-266
9[9]Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acoeptance of skin and cardiac allografts after blocking CD40 and CD2s pathways. Nature,1996,381: 434-438
10[10]Costant SL, Bottomly K. Induction of Thl and Th2 CD+4 T cell response: the alternative approaches. Annu Rev Imrnunol, 1997,15:297-312
